Cargando…

Cardiovascular Disease and Antiretroviral Therapy

Detalles Bibliográficos
Autor principal:	Jarwani, Bhavesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733197/ https://www.ncbi.nlm.nih.gov/pubmed/31543649 http://dx.doi.org/10.4103/jgid.jgid_4_18

Ejemplares similares

Emergency Departments need Psychiatric Emergency Protocols!
por: Jarwani, Bhavesh
Publicado: (2017)

Demographic, epidemiologic and clinical profile of snake bite cases, presented to Emergency Medicine department, Ahmedabad, Gujarat
por: Jarwani, Bhavesh, et al.
Publicado: (2013)

Study of various clinical and laboratory parameters among 178 patients affected by hooch tragedy in Ahmedabad, Gujarat (India): A single center experience
por: Jarwani, Bhavesh S, et al.
Publicado: (2013)

The first decade of antiretroviral therapy in Africa
por: Ford, Nathan, et al.
Publicado: (2011)

Rare combination of bilateral putaminal necrosis, optic neuritis, and polyneuropathy in a case of acute methanol intoxication among patients met with hooch tragedy in Gujarat, India
por: Jarwani, Bhavesh S, et al.
Publicado: (2012)

Ultrasound guided Deep Vein cannulation: “Perpendicular Insertion Technique (PIT)”, an edge over “Conventional Insertion Technique (CIT)”
por: Jarwani, Bhavesh S, et al.
Publicado: (2015)

Maximizing the benefits of antiretroviral therapy for key affected populations
por: Grubb, Ian R, et al.
Publicado: (2014)

Central obesity & dyslipidemia in HIV patients on antiretroviral therapy
por: Kumar, Sanjay, et al.
Publicado: (2018)

Immediate Antiretroviral Therapy: The Need for a Health Equity Approach
por: Mgbako, Ofole, et al.
Publicado: (2020)

Beta-Adrenergic gene therapy for cardiovascular disease
por: Eckhart, Andrea D, et al.
Publicado: (2000)

The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?
por: Lee, Sulggi A., et al.
Publicado: (2016)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
por: Rai, M. Ali, et al.
Publicado: (2022)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV Infection
por: Funderburg, Nicholas T.
Publicado: (2016)

Assessing the capacity and findings of routine programmatic data in Kenya to guide decision-making around contraceptives and antiretroviral therapy
por: Tippett Barr, Beth A.
Publicado: (2021)

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
por: Shehadeh, Naim, et al.
Publicado: (2018)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
por: Faridi, Kamil F., et al.
Publicado: (2023)

A complex system of chemokines may hold the key to optimal CD4+ T-cell recovery after antiretroviral therapy
por: Sun, Yan V., et al.
Publicado: (2020)

Highly active antiretroviral treatment for the prevention of HIV transmission
por: Granich, Reuben, et al.
Publicado: (2010)

Preferred antiretroviral drugs for the next decade of scale up
por: Andrieux-Meyer, Isabelle, et al.
Publicado: (2012)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

HIV Infection, Antiretroviral Therapy and Cardiovascular Risk
por: de Gaetano Donati, Katleen, et al.
Publicado: (2010)

Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new “test and treat” policy of the World Health Organization?
por: Nansseu, Jobert Richie N., et al.
Publicado: (2017)

Can we stop AIDS with antiretroviral-based treatment as prevention?
por: Mills, Edward J, et al.
Publicado: (2013)

The next generation of the World Health Organization's global antiretroviral guidance
por: Hirnschall, Gottfried, et al.
Publicado: (2013)

Addressing the Bias in Cardiovascular Care: Missed & Delayed Diagnosis of Cardiovascular Disease in Women
por: Johnson, Heather M., et al.
Publicado: (2021)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Revolutionizing cardiovascular medicine: targeted therapies for the cardiac conduction system
por: Garry, Daniel J., et al.
Publicado: (2022)

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life
por: Maswabi, Kenneth, et al.
Publicado: (2020)

Infection as a Trigger for Cardiovascular Disease
por: Alpert, Joseph S.
Publicado: (2020)

The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030
por: Ndashimye, Emmanuel, et al.
Publicado: (2019)

Sustaining the community dispensation strategy of HIV antiretroviral through community participation
por: Kameni, Bibiane Siaheu, et al.
Publicado: (2019)

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1–Infected Adults in the United States
por: Mukerji, Shibani S, et al.
Publicado: (2018)

Bone marrow cell therapy in cardiovascular disease drives us slowly to a better identification of the active cell component
por: Smadja, David M
Publicado: (2014)

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
por: Sax, Paul E, et al.
Publicado: (2019)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Genetic Susceptibility to Oxidative Stress and Cardiovascular Disease
por: Huggins, Gordon S.
Publicado: (2015)

Clocks and Cholesterol: Co-agonists in Cardiovascular Disease?
por: Fekry, Baharan, et al.
Publicado: (2017)

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
por: Fairlie, Lee, et al.
Publicado: (2019)

COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages
por: Dada, David Adelekan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lpk8t5gapjm2m420sip8r75hbi